Abstract
Src tyrosine kinase plays key roles in signal transduction following growth factor stimulation and integrin-mediated cell-substrate adhesion. Since src-signal transduction defects are implicated in a multitude of human diseases, we have sought to develop new ways to identify small molecule inhibitors using a yeast-based, activated-src over-expression system. In the present study, we describe the identification of a unique src-signal transduction inhibitor, UCS15A. UCS15A was found to inhibit the src specific tyrosine phosphorylation of numerous proteins in v-src-transformed cells. Two of these phosphoproteins were identified as bona-fide src substrates, cortactin and Sam68. UCS15A differed from conventional src-inhibitors in that it did not inhibit the tyrosine kinase activity of src. In addition, UCS15A appeared to differ from src-destabilizing agents such as herbimycin and radicicol that destabilize src by interfering with Hsp90. Our studies suggest that UCS15A exerted its src-inhibitory effects by a novel mechanism that involved disruption of protein-protein interactions mediated by src. One of the biological consequences of src-inhibition by UCS15A was its ability to inhibit the bone resorption activity of osteoclasts in vitro. These data suggest that UCS15A may inhibit the bone resorption activity of osteoclasts, not by inhibiting src tyrosine kinase activity, but by disrupting the interaction of proteins associated with src, thereby modulating downstream events in the src signal transduction pathway.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Akatsu T, Tamura T, Takahashi N, Udagawa N, Tanaka S, Sasaki T, Yamaguchi A, Nagata N, Suda T . 1992 J. Bone Miner. Res. 7: 1297–1306
Blair HC, Jordan SE, Peterson TG, Barnes S . 1996 J. Cell. Biochem. 61: 629–637
Bolen JB, Veillette A, Schwartz AM, DeSeau V, Rosen N . 1987 Proc. Natl. Acad. Sci. USA 84: 2251–2255
Boyce B, Yoneda T, Lowe C, Soriano P, Mundy G . 1992 J. Clin. Invest. 90: 1622–1627
Broome MA, Hunter T . 1996 J. Biol. Chem. 271: 16798–16806
Brown MT, Cooper JA . 1996 Biochim. Biophys. Acta. 1287: 121–149
Brugge JS, Jarosik G, Andersen J, Queral-Lustig A, Fedor-Chaiken M, Broach JR . 1987 Mol. Cell. Biol. 7: 2180–2187
Chackalaparampil I, Shalloway D . 1988 Cell 52: 801–810
Cheng H-C, Nishio H, Hatase O, Ralph S, Wang JH . 1992 J. Biol. Chem. 267: 9248–9256
Dalgarno DC, Botfield MC, Rickles RJ . 1998 Biopolymers. 43: 383–400
Erpel T, Alonso G, Roche S, Courtneidge SA . 1996 J. Biol. Chem. 271: 16807–16812
Fischer RS, Quinlan MP . 2000 Virol. 269: 404–419
Fukazawa H, Li P-M, Yamamoto C, Murakami Y, Mizuno S, Uehara Y . 1991 Biochem. Pharmacol. 42: 1661–1671
Fukui Y, O'Brien MC, Hanafusa H . 1991 Mol. Cell. Biol. 11: 1207–1213
Fumagalli S, Totty NF, Hsuan JJ, Courtneidge S . 1994 Nature 368: 871–874
Hall GE, Alexander DK . 1987 Calcif. Tiss. Int. 40: 212–218
Hall TJ, Schaeublin M, Missbach M . 1994 Biochem. Biophys. Res. Commun. 199: 1237–1244
Hanke JH, Gardner JP, Dow RL, Changelian PS, Brisette WH, Weringer EJ, Pollok BA, Connelley PA . 1996 J. Biol. Chem. 271: 695–701
Huang J, Zhang B-T, Li Y, Mayer B, Carraway KL, Carraway CAC . 1999 Oncogene 18: 4099–4107
Hunter T, Sefton BM . 1980 Proc. Natl. Acad. Sci. USA 77: 1311–1315
Jacobs C, Rubsamen H . 1983 Cancer Res. 43: 1696–1702
Kamps MP, Sefton BM . 1988 Oncogene 2: 305–315
Kanner SB, Reynolds AB, Vines RR, Parsons JT . 1990 Proc. Natl. Acad. Sci. USA 87: 3328–3332
Kaplan KB, Bibbins KB, Swedlow JR, Arnaud M, Morgan DO, Varmus H . 1994 EMBO J. 13: 4745–4756
Kaplan KB, Swedlow JR, Morgan DO, Varmus HE . 1995 Genes Dev. 9: 1505–1517
Kay BK, Williamson MP, Sudol M . 2000 FASEB J. 14: 231–241
Kornbluth S, Jove R, Hanafusa H . 1987 Proc. Natl. Acad. Sci. USA 84: 4455–4459
Kurihara N, Civin CL, Roodman GD . 1990 Endocrinol. 126: 2733–2741
Kwon HJ, Yoshida M, Abe K, Horinouchi S, Beppu T . 1992b Biosci. Biotech. Biochem. 56: 538–539
Kwon HJ, Yoshida M, Fukui Y, Horinouchi S, Beppu T . 1992a Cancer Res. 52: 6926–6930
Kwon HJ, Yoshida M, Muroya K, Hattori S, Nishida E, Fukui Y, Beppu T, Horinouchi S . 1995 J. Biochem. 118: 221–228
Lowe C, Yoneda T, Boyce BF, Chen H, Mundy GR, Soriano P . 1993 Proc. Natl. Acad. Sci. USA 90: 4485–4489
Luttrell LM, Daaka Y, Lefkowitz RJ . 1999 Curr. Opin. Cell Biol. 11: 177–183
Manolagas SC . 2000 Endocr. Rev. 21: 115–137
Missbach M, Jeschke M, Feyen J, Muller K, Glatt M, Susa M . 1999 Bone 24: 437–439
Miyazaki T, Takayanagi H, Isshiki M, Takahashi T, Okada M, Fukui Y, Oda H, Nakamura K, Hirai H, Kurokawa T, Tanaka S . 2000 J. Bone Miner. Res. 15: 41–51
Mosmann T . 1983 J. Immunol. Meth. 65: 55–63
Okamura H, Resh MD . 1994 Oncogene 9: 2293–2303
Roe MS, Prodromou C, O'Brien R, Ladbury JE, Piper PW, Pearl LH . 1999 J. Med. Chem. 42: 260–266
Roodman GD . 1999 Exp. Hematol. 27: 1229–1241
Schaller MD, Hildebrand JD, Shannon JD, Fox JW, Vines RR, Parsons JT . 1994 Mol. Cell. Biol. 14: 1680–1688
Schlaepfer DD, Broome MA, Hunter T . 1997 Mol. Cell. Biol. 17: 1702–1713
Schulte TW, Akinaga S, Agatsuma T, Murakata T, Sugimoto S, Nakano H, Simen BB, Argon Y, Toft DO, Neckers LM, Sharma SV . 1999 Mol. Endocrinol. 13: 1435–1448
Schulte TW, Akinaga S, Soga S, Sullivan W, Stensgard B, Toft D, Neckers LM . 1998 Cell Stress and Chaperones 3: 100–108
Schwartzberg PL . 1998 Oncogene 17: 1463–1468
Schwartzberg PL, Xing L, Hoffmann O, Lowell CA, Garrett L, Boyce BF, Varmus HE . 1997 Genes Dev. 11: 2835–2844
Sharma S, Agatsuma T, Nakano H . 1998 Oncogene 16: 2639–2645
Shen Z, Batzer A, Koehler JA, Polakis PP, Schlessinger J, Lydon NB, Moran MF . 1999 Oncogene 18: 4647–4653
Sicheri F, Moarefi I, Kuriyan J . 1997 Nature 385: 602–609
Songyang Z, Blechner S, Hoagland N, Hoekstra MF, Piwnica-Worms H, Cantley LC . 1994 Curr. Biol. 4: 973–982
Soriano P, Montgomery C, Geske R, Bradley A . 1991 Cell 64: 693–702
Stebbins CE, Russo AA, Schneider C, Rosen N, Hartl FU, Pavletich NP . 1997 Cell 89: 239–250
Stehlin D, Varmus HE, Bishop JM, Vogt PK . 1976 Nature 260: 170–173
Sugawara K, Hamada M, Hosoi S, Tamaoki T . 1998 Anal. Biochem. 255: 204–210
Suzuki G, Kobayashi I, Mitsutake . 1983 Patent # JP58116686). Japan Kokai Tokkyo Koho
Taylor SJ, Shalloway D . 1994 Nature 368: 867–871
Thomas SM, Brugge JS . 1997 Annu. Rev. Cell. Dev. Biol. 13: 513–609
Twamley-Stein GM, Pepperkok R, Ansorge W, Courtneidge SA . 1993 Proc. Natl. Acad. Sci. USA 90: 7697–7700
Uehara Y, Hori M, Takeuchi T, Umezawa H . 1985 Jpn. J. Cancer Res. 76: 672–675
Uehara Y, Murakami Y, Suzukake-Tsuchiya K, Moriya Y, Sano H, Shibata K, Omura S . 1988 J. Antibiot. 41: 831–834
Violette SM, Shakespeare WC, Barlette C, Guan W, Smith JA, Rickles RJ, Bohacek RS, Holt DA, Baron R, Sawyer TK . 1999 Chem. Biol. 7: 225–235
Weng Z, Thomas SM, Rickles RJ, Taylor JA, Brauer AW, Seidel-Dugan C, Michael WM, Dreyfuss G, Brugge JS . 1994 Mol. Cell. Biol. 14: 4509–4521
Whitesell L, Mimnaugh EG, De CB, Myers CE, Neckers LM . 1994 Proc. Natl. Acad. Sci. USA 91: 8324–8328
Wu H, Reynolds AB, Kanner SB, Vines RR, Parsons JT . 1991 Mol. Cell. Biol. 11: 5113–5124
Xu W, Harrison SC, Eck MJ . 1997 Nature 385: 595–602
Yamaguchi H, Hendrickson WA . 1996 Nature 384: 484–489
Yoneda T, Lowe C, Lee C-H, Gutierrez G, Niewolna M, Williams PJ, Izbicka E, Uehara Y, Mundy GR . 1993 J. Clin. Invest. 91: 2791–2795
Zhao JF, Nakano H, Sharma S . 1995 Oncogene 11: 161–173
Zhu T, Goh ELK, LeRoith D, Lobie PE . 1998 J. Biol. Chem. 273: 33864–33875
Acknowledgements
We thank Dr Margaret Quinlan for the critical reading of this manuscript and for her helpful discussion. The technical assistance of Miss H Tsunoda is gratefully acknowledged.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Sharma, S., Oneyama, C., Yamashita, Y. et al. UCS15A, a non-kinase inhibitor of Src signal transduction. Oncogene 20, 2068–2079 (2001). https://doi.org/10.1038/sj.onc.1204296
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1204296
Keywords
This article is cited by
-
Sam68 is a druggable vulnerability point in cancer stem cells
Cancer and Metastasis Reviews (2023)
-
UCS15A, a novel small molecule, SH3 domain-mediated protein–protein interaction blocking drug
Oncogene (2002)